We are testing a new nasal treatment to see if it is safe and effective for patients. This study also explores how it affects the nasal microbiome.
Health conditions and diseases that the clinical trial is designed to study and treat.
Nasal colonization with methicillin-susceptible Staphylococcus aureus (MSSA) occurs when this bacteria is present in the nasal passages without causing an active infection. While many people carry this bacteria harmlessly, it can lead to infections, especially in those with weakened immune systems.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.